Approval · Notice of Compliance 998 · 2000
PENGLOBE: Notice of Compliance 998
Issued April 19, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 998
- Date
- April 19, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- BACAMPICILLIN HCL 400 MG per TAB
- BACAMPICILLIN HCL 800 MG per TAB